Food & Drug Inspection Monitor

摘要

Drugs/Medical Devices: American Peptide Company, Vista, CA; Bausch & Lomb, Greenville, SC; Medical Devices: Carolina Liquid Chemistries Corp., Brea, CA; Diazyme Laboratories Division, General Atomics, San Diego, CA; Lifecore Biomedical, Chaska, MN; Resonance Technology, Northridge, CA; Direct Final Rule on GMPs for Phase I INDs withdrawn due to strong industry response.